Enanta Pharmaceuticals shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $10M | 867k | 11.96 |
| 2025-06-30 | $6.6M | 867k | 7.56 |
| 2025-03-31 | $4.8M | 867k | 5.52 |
| 2024-12-31 | $4.9M | 849k | 5.75 |
| 2024-09-30 | $8.8M | 849k | 10.36 |
| 2024-06-30 | $11M | 849k | 12.97 |
| 2024-03-31 | $15M | 854k | 17.46 |
| 2023-09-30 | $6.1M | 549k | 11.16 |
| 2023-06-30 | $2.1M | 101k | 21.38 |
| 2022-06-30 | $2.0M | 43k | 47.28 |
| 2022-03-31 | $5.1M | 72k | 71.09 |
| 2021-12-31 | $9.9M | 133k | 74.67 |
| 2021-09-30 | $14M | 239k | 56.72 |
| 2021-06-30 | $16M | 367k | 44.02 |
| 2021-03-31 | $23M | 464k | 49.32 |
| 2020-12-31 | $20M | 468k | 42.10 |
| 2020-09-30 | $22M | 469k | 45.78 |
| 2020-06-30 | $21M | 413k | 50.21 |
| 2020-03-31 | $18M | 344k | 51.43 |
| 2019-12-31 | $21M | 345k | 61.79 |
| 2019-09-30 | $20M | 340k | 60.09 |
| 2019-06-30 | $34M | 405k | 84.38 |
| 2019-03-31 | $37M | 391k | 95.52 |
| 2018-12-31 | $25M | 347k | 70.84 |
| 2018-09-30 | $38M | 447k | 85.45 |
| 2018-06-30 | $44M | 382k | 115.90 |
| 2018-03-31 | $18M | 221k | 80.91 |
| 2017-12-31 | $1.5M | 26k | 58.69 |
| 2017-03-31 | $8.1M | 262k | 30.80 |
| 2016-12-31 | $19M | 569k | 33.50 |
| 2016-09-30 | $9.8M | 369k | 26.61 |
| 2016-06-30 | $15M | 690k | 22.05 |
| 2016-03-31 | $24M | 808k | 29.37 |
| 2015-12-31 | $27M | 809k | 33.02 |
| 2015-09-30 | $27M | 736k | 36.14 |
| 2015-06-30 | $12M | 267k | 44.99 |
| 2015-03-31 | $91k | 3.0k | 30.68 |